Literature DB >> 11879201

Mechanism of the regulation of type IB phosphoinositide 3OH-kinase byG-protein betagamma subunits.

Sonja Krugmann1, Matthew A Cooper, Dudley H Williams, Phillip T Hawkins, Len R Stephens.   

Abstract

Type IB phosphoinositide 3OH-kinase (PI3K) is activated by G-protein betagamma subunits (Gbetagammas). The enzyme is soluble and largely cytosolic in vivo. Its substrate, PtdIns(4,5)P(2), and the Gbetagammas are localized at the plasma membrane. We have addressed the mechanism by which Gbetagammas regulate the PI3K using an in vitro approach. We used sedimentation assays and surface plasmon resonance to determine association of type IB PI3K with lipid monolayers and vesicles of varying compositions, some of which had Gbetagammas incorporated. Association and dissociation rate constants were determined. Our results indicated that in an assay situation in vitro the majority of PI3K will be associated with lipid vesicles, irrespective of the presence or absence of Gbetagammas. In line with this, a constitutively active membrane-targeted PI3K construct could still be activated substantially by Gbetagammas in vitro. We conclude that Gbetagammas activate type IB PI3K by a mechanism other than translocation to the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11879201      PMCID: PMC1222438          DOI: 10.1042/0264-6021:3620725

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

1.  Characterizing the interactions between the two subunits of the p101/p110gamma phosphoinositide 3-kinase and their role in the activation of this enzyme by G beta gamma subunits.

Authors:  S Krugmann; P T Hawkins; N Pryer; S Braselmann
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

2.  SH2 domains of the p85 alpha subunit of phosphatidylinositol 3-kinase regulate binding to growth factor receptors.

Authors:  C J McGlade; C Ellis; M Reedijk; D Anderson; G Mbamalu; A D Reith; G Panayotou; P End; A Bernstein; A Kazlauskas
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

3.  Surface plasmon resonance analysis at a supported lipid monolayer.

Authors:  M A Cooper; A C Try; J Carroll; D J Ellar; D H Williams
Journal:  Biochim Biophys Acta       Date:  1998-08-14

4.  PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells.

Authors:  K R Auger; L A Serunian; S P Soltoff; P Libby; L C Cantley
Journal:  Cell       Date:  1989-04-07       Impact factor: 41.582

5.  Gbeta 5gamma 2 is a highly selective activator of phospholipid-dependent enzymes.

Authors:  U Maier; A Babich; N Macrez; D Leopoldt; P Gierschik; D Illenberger; B Nurnberg
Journal:  J Biol Chem       Date:  2000-05-05       Impact factor: 5.157

6.  Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase.

Authors:  M Otsu; I Hiles; I Gout; M J Fry; F Ruiz-Larrea; G Panayotou; A Thompson; R Dhand; J Hsuan; N Totty
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

7.  Pathway of phosphatidylinositol(3,4,5)-trisphosphate synthesis in activated neutrophils.

Authors:  L R Stephens; K T Hughes; R F Irvine
Journal:  Nature       Date:  1991-05-02       Impact factor: 49.962

8.  Bifurcation of lipid and protein kinase signals of PI3Kgamma to the protein kinases PKB and MAPK.

Authors:  T Bondeva; L Pirola; G Bulgarelli-Leva; I Rubio; R Wetzker; M P Wymann
Journal:  Science       Date:  1998-10-09       Impact factor: 47.728

9.  Structural insights into phosphoinositide 3-kinase catalysis and signalling.

Authors:  E H Walker; O Perisic; C Ried; L Stephens; R L Williams
Journal:  Nature       Date:  1999-11-18       Impact factor: 49.962

10.  Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma.

Authors:  M E Pacold; S Suire; O Perisic; S Lara-Gonzalez; C T Davis; E H Walker; P T Hawkins; L Stephens; J F Eccleston; R L Williams
Journal:  Cell       Date:  2000-12-08       Impact factor: 41.582

View more
  8 in total

Review 1.  Crossroads of PI3K and Rac pathways.

Authors:  Carlo C Campa; Elisa Ciraolo; Alessandra Ghigo; Giulia Germena; Emilio Hirsch
Journal:  Small GTPases       Date:  2015-05-05

2.  Rac activation: P-Rex1 - a convergence point for PIP(3) and Gbetagamma?

Authors:  Orion D Weiner
Journal:  Curr Biol       Date:  2002-06-25       Impact factor: 10.834

3.  A3 adenosine and CB1 receptors activate a PKC-sensitive Cl- current in human nonpigmented ciliary epithelial cells via a G beta gamma-coupled MAPK signaling pathway.

Authors:  Chanjuan Shi; Anna Szczesniak; Lucy Mao; Christine Jollimore; Miguel Coca-Prados; Orlando Hung; Melanie E M Kelly
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

Review 4.  Function, Regulation and Biological Roles of PI3Kγ Variants.

Authors:  Bernd Nürnberg; Sandra Beer-Hammer
Journal:  Biomolecules       Date:  2019-08-30

5.  The p110delta isoform of PI 3-kinase negatively controls RhoA and PTEN.

Authors:  Evangelia A Papakonstanti; Anne J Ridley; Bart Vanhaesebroeck
Journal:  EMBO J       Date:  2007-06-21       Impact factor: 11.598

6.  p110δ PI3 kinase pathway: emerging roles in cancer.

Authors:  Niki Tzenaki; Evangelia A Papakonstanti
Journal:  Front Oncol       Date:  2013-03-01       Impact factor: 6.244

7.  Roles of G beta gamma in membrane recruitment and activation of p110 gamma/p101 phosphoinositide 3-kinase gamma.

Authors:  Carsten Brock; Michael Schaefer; H Peter Reusch; Cornelia Czupalla; Manuela Michalke; Karsten Spicher; Günter Schultz; Bernd Nürnberg
Journal:  J Cell Biol       Date:  2002-12-30       Impact factor: 10.539

8.  G protein-independent Ras/PI3K/F-actin circuit regulates basic cell motility.

Authors:  Atsuo T Sasaki; Chris Janetopoulos; Susan Lee; Pascale G Charest; Kosuke Takeda; Lauren W Sundheimer; Ruedi Meili; Peter N Devreotes; Richard A Firtel
Journal:  J Cell Biol       Date:  2007-07-16       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.